Dynamic HER2 reassessment and precision sequencing after trastuzumab in HER2-positive advanced gastric cancer
ESMO Gastrointestinal Oncology
· Elsevier
The publisher did not provide an abstract — full text is available via the link below.
Read at publisher →
Citation
Dynamic HER2 reassessment and precision sequencing after trastuzumab in HER2-positive advanced gastric cancer. // ESMO Gastrointestinal Oncology. – URL: https://www.sciencedirect.com/science/article/pii/S294981982600049X?dgcid=rss_sd_all
Dynamic HER2 reassessment and precision sequencing after trastuzumab in HER2-positive advanced gastric cancer. ESMO Gastrointestinal Oncology. https://www.sciencedirect.com/science/article/pii/S294981982600049X?dgcid=rss_sd_all
“Dynamic HER2 reassessment and precision sequencing after trastuzumab in HER2-positive advanced gastric cancer.” ESMO Gastrointestinal Oncology.
@article{article44783,
title = {Dynamic HER2 reassessment and precision sequencing after trastuzumab in HER2-positive advanced gastric cancer},
journal = {ESMO Gastrointestinal Oncology},
url = {https://www.sciencedirect.com/science/article/pii/S294981982600049X?dgcid=rss_sd_all}
}